{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:17Z","timestamp":1792189157644,"version":"4.4.0"},"reference-count":41,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2025,10,31]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                      pneumonia (PcP) in HIV-negative patients is associated with high mortality rates. While early adjunctive corticosteroid (AC) therapy benefits HIV-positive patients with severe PcP, its efficacy and safety in HIV-negative patients remain poorly investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicentre retrospective observational study included consecutive patients diagnosed with proven or probable PcP, from January 2011 to January 2021. This study assessed the prognostic impact and safety of early AC in HIV-negative patients with PcP. To address baseline characteristic imbalances between patients, a non-parsimonious propensity matching analysis was performed with a 1\/1 ratio. Survival analysis, day-90 mortality rate and healthcare-associated infections (HCAI) were compared using Cox and logistic regressions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      350 consecutive HIV-negative patients with proven or probable PcP were included. Of these, 116 (33.1%) received early AC within 5\u2009days of anti-PcP therapy initiation. The median arterial oxygen partial pressure to fractional inspired oxygen (PaO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      ) ratio was 224 (114\u2013229). The 90-day mortality rate was 29.4% (103\/350). There was no significant difference in 90-day mortality according to AC, both in overall and matched populations (OR 1.27 (0.78\u20132.05); p=0.336\u2009and 0.92 (0.52\u20131.62); p=0.772, respectively). HCAI incidences appeared similar between groups. In the matched population, a higher proportion of AC patients required high-flow oxygen therapy (OR 2.15 (1.17\u20134.05); p=0.015) and mechanical ventilation duration was higher in corticosteroid recipients (OR 1.04 (1.01\u20131.09); p=0.048).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early AC therapy was not associated with reduced 90-day mortality in HIV-negative PcP patients. Although recommended in hypoxemic HIV-positive PcP patients, the benefit of this strategy in HIV-negative patients remains to be proven.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2025-223504","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T11:45:11Z","timestamp":1765367111000},"page":"591-599","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic impact and safety of early adjunctive corticosteroid therapy in HIV-negative severe\n                    <i>pneumocystis<\/i>\n                    pneumonia: a propensity-matched multicentre study"],"prefix":"10.1136","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9871-636X","authenticated-orcid":false,"given":"Florian","family":"Reizine","sequence":"first","affiliation":[{"name":"Service de R\u00e9animation Polyvalente, Groupement Hospitalier Broceliande Atlantique, Brittany, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Stiegler","sequence":"additional","affiliation":[{"name":"Service de Maladies Infectieuses et Tropicales, CHU Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Lecuyer","sequence":"additional","affiliation":[{"name":"Service de Maladies Infectieuses et Tropicales, CHU Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Tessoulin","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, CHU Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Rieul","sequence":"additional","affiliation":[{"name":"Service de R\u00e9animation Polyvalente, Groupement Hospitalier Broceliande Atlantique, Brittany, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Camou","sequence":"additional","affiliation":[{"name":"Intensive Care and Infectious Disease Unit, CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Morio","sequence":"additional","affiliation":[{"name":"Laboratoire de Mycologie-Parasitologie, H\u00f4tel-Dieu, CHU Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cady","sequence":"additional","affiliation":[{"name":"Laboratoire de Microbiologie, Groupement Hospitalier Broceliande Atlantique, Brittany, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Gabriel","sequence":"additional","affiliation":[{"name":"Laboratoire de Mycologie, CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, CHU Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Raffi","sequence":"additional","affiliation":[{"name":"Service de Maladies Infectieuses et Tropicales, CHU Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutoille","sequence":"additional","affiliation":[{"name":"Service de Maladies Infectieuses et Tropicales, CHU Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nah\u00e9ma","family":"Issa","sequence":"additional","affiliation":[{"name":"Service de Maladies Infectieuses, CHU Bordeaux GH Pellegrin, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Jean","family":"Gaborit","sequence":"additional","affiliation":[{"name":"Service de Maladies Infectieuses et Tropicales, CHU Nantes, Nantes, France"},{"name":"Universit\u00e9 de Nantes, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"2026051403202057000_81.6.591.1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cmi.2023.04.015","article-title":"How to diagnose and treat a patient without human immunodeficiency virus infection having Pneumocystis jirovecii pneumonia?","volume":"29","author":"H\u00e4nsel","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026051403202057000_81.6.591.2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2009.131668"},{"key":"2026051403202057000_81.6.591.3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13613-024-01309-y","article-title":"Pneumocystis pneumonia in French intensive care units in 2013-2019: mortality and immunocompromised conditions","volume":"14","author":"Kamel","year":"2024","journal-title":"Ann Intensive Care"},{"key":"2026051403202057000_81.6.591.4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.amjmed.2014.07.010","article-title":"Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients","volume":"127","author":"Fillatre","year":"2014","journal-title":"Am J Med"},{"key":"2026051403202057000_81.6.591.5","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s00134-024-07489-2","article-title":"Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study","volume":"50","author":"Kamel","year":"2024","journal-title":"Intensive Care Med"},{"key":"2026051403202057000_81.6.591.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.03.018"},{"key":"2026051403202057000_81.6.591.7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pulmoe.2019.04.003","article-title":"Pneumocystosis pneumonia: A comparison study between HIV and non-HIV immunocompromised patients","volume":"25","author":"Rego de Figueiredo","year":"2019","journal-title":"Pulmonology"},{"key":"2026051403202057000_81.6.591.8","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection","volume":"2015","author":"Ewald","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051403202057000_81.6.591.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011223232104"},{"key":"2026051403202057000_81.6.591.10","article-title":"Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit","volume":"8","author":"Gharamti","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"2026051403202057000_81.6.591.11","doi-asserted-by":"crossref","DOI":"10.3390\/jof7080625","article-title":"Immune Response in Pneumocystis Infections According to the Host Immune System Status","volume":"7","author":"Charpentier","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2026051403202057000_81.6.591.12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S2213-2600(25)00125-0","article-title":"Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial","volume":"13","author":"Lemiale","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026051403202057000_81.6.591.13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.chest.2024.04.038","article-title":"Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study","volume":"166","author":"Gaborit","year":"2024","journal-title":"Chest"},{"key":"2026051403202057000_81.6.591.14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.chest.2024.01.015","article-title":"Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study","volume":"165","author":"L\u00e9cuyer","year":"2024","journal-title":"Chest"},{"key":"2026051403202057000_81.6.591.15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13613-019-0604-x","article-title":"Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study","volume":"9","author":"Gaborit","year":"2019","journal-title":"Ann Intensive Care"},{"key":"2026051403202057000_81.6.591.16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/infdis\/jiab460","article-title":"Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of Pneumocystis jirovecii Pneumonia","volume":"225","author":"L\u00e9cuyer","year":"2022","journal-title":"J Infect Dis"},{"key":"2026051403202057000_81.6.591.17","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00649-9"},{"key":"2026051403202057000_81.6.591.18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijid.2018.12.001","article-title":"Adjunctive Corticosteroids decreased the risk of mortality of non-HIV Pneumocystis Pneumonia","volume":"79","author":"Inoue","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2026051403202057000_81.6.591.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.04.026"},{"key":"2026051403202057000_81.6.591.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-2078-z"},{"key":"2026051403202057000_81.6.591.21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/1346-8138.15294","article-title":"Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"47","author":"Tohyama","year":"2020","journal-title":"J Dermatol"},{"key":"2026051403202057000_81.6.591.22","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-04097-8","article-title":"Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS","volume":"26","author":"Lamouche-Wilquin","year":"2022","journal-title":"Crit Care"},{"key":"2026051403202057000_81.6.591.23","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1730-7"},{"key":"2026051403202057000_81.6.591.24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026051403202057000_81.6.591.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510240069035"},{"key":"2026051403202057000_81.6.591.26","unstructured":"Clinical application of blood gases by Barry A. Shapiro. Open Library. Available: https:\/\/openlibrary.org\/books\/OL2048871M\/Clinical_application_of_blood_gases [Accessed 12 Nov 2024]."},{"key":"2026051403202057000_81.6.591.27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw353"},{"key":"2026051403202057000_81.6.591.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250611","article-title":"Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: A propensity score analysis","volume":"16","author":"Assal","year":"2021","journal-title":"PLoS ONE"},{"key":"2026051403202057000_81.6.591.29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1186\/s12879-024-10151-3","article-title":"Effectiveness of pulse methylprednisolone in patients with non-human immunodeficiency virus pneumocystis pneumonia: a multicentre, retrospective registry-based cohort study","volume":"24","author":"Morimoto","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2026051403202057000_81.6.591.30","first-page":"1","article-title":"Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America","volume":"53","author":"Mofenson","year":"2004","journal-title":"MMWR Recomm Rep"},{"key":"2026051403202057000_81.6.591.31","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"2026051403202057000_81.6.591.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"2026051403202057000_81.6.591.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-023-04608-1","article-title":"Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG","volume":"27","author":"Giacobbe","year":"2023","journal-title":"Crit Care"},{"key":"2026051403202057000_81.6.591.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010307"},{"key":"2026051403202057000_81.6.591.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1711-z","article-title":"Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study","volume":"16","author":"Bodilsen","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2026051403202057000_81.6.591.36","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000217961.75225.E9"},{"key":"2026051403202057000_81.6.591.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215145"},{"key":"2026051403202057000_81.6.591.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"2026051403202057000_81.6.591.39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13613-025-01503-6","article-title":"Respiratory management of critically ill pneumocystis pneumonia patients: a multicenter retrospective study","volume":"15","author":"Reizine","year":"2025","journal-title":"Ann Intensive Care"},{"key":"2026051403202057000_81.6.591.40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.910516","article-title":"Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis","volume":"13","author":"Shapiro","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026051403202057000_81.6.591.41","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1164\/rccm.201712-2452OC","article-title":"A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure","volume":"198","author":"Azoulay","year":"2018","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2025-223504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:22:26Z","timestamp":1778754146000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2025-223504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,14]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/thorax-2025-223504"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2025-223504","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}